Global /China /Healthcare /Biotechnology /603387
chevron_leftBack
Getein Biotech, Inc. logo

Getein Biotech, Inc.

603387
SSE: 603387 Delayed
9.65CNY 5.5%
1.43 USD
As of 19 June 2026, Getein Biotech, Inc. has a market cap of $686.71M USD, ranking #13086 globally and #3944 in China. It ranks #1186 in the Healthcare sector, and #222 in the Biotechnology industry.
Global Rank
13086
Country Rank
3944
Sector Rank
1186
Industry Rank
222
Key Stats
Market Cap
$686.71MUSD
4.64B CNY
Enterprise Value
$627.7MUSD
4.24B CNY
Revenue (TTM)
$154.3MUSD
1.04B CNY
EBITDA (TTM)
$32.82MUSD
221.77M CNY
Net Income (TTM)
$30.89MUSD
208.76M CNY
EBITDA Margin
21%
Profit Margin
20%
PE Ratio
22.3
PS Ratio
4.5
PB Ratio
1.7
EV/EBITDA
18.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Enben Su open_in_new
Employees
1,947
Founded
2002
Website
getein.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
5.5% 2.5% -3.4% 10% 18% 22%

News

Loading...

Markets

Exchange Ticker Price
Shanghai Stock Exchange
MIC: XSHG
PRIMARY
603387
基蛋生物科技股份有限公司 Class A
ISIN: CNE100002RR9
Shares Out.:
507.154M1 Shares Float: 287.936M2
TV:
SA:
YF:
GF:
BA:
MS:
9.65 CNY
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Getein Biotech, Inc.

Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection. The company was founded in 2002 and is headquartered in Nanjing, China.

Similar Companies

Industry: Biotechnology (China)
Name
Market Cap diff.
PE
$17.44B
136.71B HKD
2K%
25.3
$12.19B
95.58B HKD
2K%
22.1
$8.03B
54.23B CNY
1K%
34.4
$7.35B
49.69B CNY
971%
-
1530
$7.08B
55.5B HKD
931%
5.8
$6.74B
45.52B CNY
881%
61.6
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
26K%
23.9
GILD
$159.92B
23K%
19.0
ARGX
$47.43B
41.39B EUR
7K%
39.9
$44.23B
68.19T KRW
6K%
35.5
CSL
$42.27B
60.27B AUD
6K%
29.3
LONN
$41.88B
33.71B CHF
6K%
37.2
chevron_leftBack